Fractionated 1927-nm Non Ablative Thulium Laser in Treating Post Inflammatory Hyperpigmentation

Part of paid clinical trials in Detroit, Michigan.

Sponsor
Henry Ford Health System
Study ID
NCT06149780
Status
Recruiting
Apply to this trial

Conditions

  • Healthy

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Patients treated with laser — DEVICE
    Patients treated with laser with topical steroid Patients treated with laser with vehicle

Study Details

To study the effect of fractionated 1927-nm non ablative thulium laser in reduction of post inflammatory hyperpigmentation (PIH) using a validated and reproducible model for studying PIH. * Determine if there is aa reduction in PIH in patients treated with three (3) monthly sessions of fractionated 1927-nm non ablative thulium laser * Determine if there is efficacy of post-procedure clobetasol propionate 0.05% ointment in the management of PIH * Determine the histological and molecular changes that occur with laser and laser plus topical steroid treatment compared to untreated skin

Key Dates

Start date
Nov 15, 2023
Status verified
Mar 2025
Primary completion
Aug 1, 2026
Completion
Aug 30, 2026

Study Design

Enrollment
15 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Fractional laser patients treated with laser
    Laser with topical steroid and laser with vehicle.

Primary Outcome Measure

Degree of Pigmentation in all 5 subjects [ Time Frame: Visit 1 (Day 0) through Visit 5 (Day 112 ±5) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Henry Ford Medical CenterDetroitMichigan48202
Fanar Razoky, Bachelors
[email protected]
313-694-1923
Mohammad Tasneem, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Detroit, MI

By research site
Henry Ford Medical Center· Detroit, MI

Related Studies